Ariad Pharma's lung cancer drug gets breakthrough therapy status
October 02, 2014 at 07:53 AM EDT
Oct 2 (Reuters) - Ariad Pharmaceuticals Inc said its experimental lung cancer drug received "breakthrough therapy" status from the U.S. Food and Drug Administration, sending its shares up 7 percent premarket.
